{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-30",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "safetyreportversion": "2",
      "safetyreportid": "23102211",
      "primarysourcecountry": "CN",
      "occurcountry": "CN",
      "transmissiondateformat": "102",
      "transmissiondate": "20240410",
      "reporttype": "2",
      "serious": "2",
      "seriousnessdeath": "2",
      "seriousnesslifethreatening": "2",
      "seriousnesshospitalization": "2",
      "seriousnessdisabling": "2",
      "seriousnesscongenitalanomali": "2",
      "seriousnessother": "2",
      "receivedateformat": "102",
      "receivedate": "20231025",
      "receiptdateformat": "102",
      "receiptdate": "20240103",
      "fulfillexpeditecriteria": "1",
      "companynumb": "CN-009507513-2310CHN009122",
      "primarysource": {
        "reportercountry": "CN",
        "qualification": "1"
      },
      "sender": {
        "sendertype": "2",
        "senderorganization": "FDA-Public Use"
      },
      "receiver": {
        "receivertype": "6",
        "receiverorganization": "FDA"
      },
      "patient": {
        "patientonsetage": "35",
        "patientonsetageunit": "801",
        "patientweight": "102",
        "patientsex": "1",
        "reaction": [
          {
            "reactionmeddraversionpt": "26.1",
            "reactionmeddrapt": "Ketosis",
            "reactionoutcome": "1"
          },
          {
            "reactionmeddraversionpt": "26.1",
            "reactionmeddrapt": "Peripheral vascular disorder",
            "reactionoutcome": "6"
          }
        ],
        "drug": [
          {
            "drugcharacterization": "1",
            "medicinalproduct": "ERTUGLIFLOZIN",
            "drugauthorizationnumb": "209803",
            "drugdosageform": "Tablet",
            "drugadministrationroute": "048",
            "drugindication": "Diabetes mellitus",
            "drugstartdateformat": "102",
            "drugstartdate": "20230204",
            "actiondrug": "4",
            "activesubstance": {
              "activesubstancename": "ERTUGLIFLOZIN"
            },
            "openfda": {
              "application_number": [
                "NDA209803"
              ],
              "brand_name": [
                "STEGLATRO"
              ],
              "generic_name": [
                "ERTUGLIFLOZIN"
              ],
              "manufacturer_name": [
                "Merck Sharp & Dohme LLC"
              ],
              "product_ndc": [
                "0006-5363",
                "0006-5364"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "ERTUGLIFLOZIN PIDOLATE"
              ],
              "rxcui": [
                "1992810",
                "1992816",
                "1992819",
                "1992821"
              ],
              "spl_id": [
                "17e6fd06-3cc6-4bad-8809-76e38dbc4471"
              ],
              "spl_set_id": [
                "e6f3e718-bb99-48f1-ab94-b9f0af05fed6"
              ],
              "package_ndc": [
                "0006-5363-03",
                "0006-5363-08",
                "0006-5363-09",
                "0006-5363-06",
                "0006-5363-07",
                "0006-5363-10",
                "0006-5364-03",
                "0006-5364-08",
                "0006-5364-09",
                "0006-5364-06",
                "0006-5364-07"
              ],
              "unii": [
                "MLU731K321"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "MIGLITOL",
            "drugdosageform": "Tablet",
            "drugadministrationroute": "048",
            "drugindication": "Diabetes mellitus",
            "drugstartdateformat": "102",
            "drugstartdate": "20220709",
            "activesubstance": {
              "activesubstancename": "MIGLITOL"
            },
            "openfda": {
              "application_number": [
                "ANDA203965"
              ],
              "brand_name": [
                "MIGLITOL"
              ],
              "generic_name": [
                "MIGLITOL"
              ],
              "manufacturer_name": [
                "Westminster Pharmaceuticals, LLC"
              ],
              "product_ndc": [
                "69367-303",
                "69367-305",
                "69367-304"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "MIGLITOL"
              ],
              "rxcui": [
                "205329",
                "205330",
                "205331"
              ],
              "spl_id": [
                "d28d00da-e102-098c-e053-2995a90a8121"
              ],
              "spl_set_id": [
                "b8da2015-d254-2425-e053-2995a90acf0e"
              ],
              "package_ndc": [
                "69367-303-01",
                "69367-305-01",
                "69367-304-01"
              ],
              "nui": [
                "N0000000166",
                "N0000175559"
              ],
              "pharm_class_moa": [
                "alpha Glucosidase Inhibitors [MoA]"
              ],
              "pharm_class_epc": [
                "alpha-Glucosidase Inhibitor [EPC]"
              ],
              "unii": [
                "0V5436JAQW"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "BEINAGLUTIDE",
            "drugdosagetext": "UNK",
            "drugdosageform": "Solution for injection",
            "drugindication": "Diabetes mellitus",
            "drugstartdateformat": "102",
            "drugstartdate": "20230204",
            "drugenddateformat": "102",
            "drugenddate": "20230504",
            "drugtreatmentduration": "90",
            "drugtreatmentdurationunit": "804",
            "activesubstance": {
              "activesubstancename": "BEINAGLUTIDE"
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "METFORMIN HYDROCHLORIDE;PIOGLITAZONE HYDROCHLORIDE",
            "drugdosagetext": "UNK",
            "drugdosageform": "Tablet",
            "drugindication": "Diabetes mellitus",
            "drugstartdateformat": "102",
            "drugstartdate": "20230204",
            "drugenddateformat": "102",
            "drugenddate": "20230628",
            "drugtreatmentduration": "145",
            "drugtreatmentdurationunit": "804"
          }
        ],
        "summary": {
          "narrativeincludeclinical": "CASE EVENT DATE: 20230504"
        }
      }
    }
  ]
}